Levetiracetam Tablet, For Suspension
Product Images NDC 66993-101

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 66993-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Recommended Dosage Adjustment Formula (Levetiracetam 1)

This text provides formulas for estimating the glomerular filtration rate (GFR) in adults based on age, weight, gender, and serum creatinine levels. It uses age, weight, and serum creatinine as variables to calculate GFR. The formula adjusts for gender by multiplying by 0.85 for female patients.*

FDA Label Image

Figure 3 (Levetiracetam 10)

Percentage distribution of participants receiving placebo and Levetiracetam at a dosage of 3000mg/day: Placebo - 39.4%, Levetiracetam - 14.4%. 104 participants received placebo, while 180 participants received Levetiracetam at the specified dosage.*

FDA Label Image

Figure 4 (Levetiracetam 11)

FDA Label Image

Figure 5 (Levetiracetam 12)

This data table provides the percentage of patients in two groups, Placebo (N=84) and Levetiracetam (N=79), with values ranging from 0% to 100%. The percentage of patients is shown alongside the corresponding percentage values from 0% to 100%.*

FDA Label Image

Imprint Marking (Levetiracetam 13)

FDA Label Image

Carton 250 (Levetiracetam 14)

This text appears to be a set of instructions for a medication product called Levetiracetam, which comes in the form of tablets for oral suspension. It specifies the content of each tablet and provides guidance on administration. The product seems to be intended for institutional use based on the provided information.*

FDA Label Image

Recommended Dosage Adjustment Formula (Levetiracetam 2)

FDA Label Image

Imprint Marking (Levetiracetam 3)

FDA Label Image

Imprint Marking (Levetiracetam 4)

FDA Label Image

Imprint Marking (Levetiracetam 5)

FDA Label Image

Imprint Marking (Levetiracetam 6)

FDA Label Image

Chemical Structure (Levetiracetam 7)

FDA Label Image

Figure 1 (Levetiracetam 8)

This text represents a visualization of the percentage of patients in different treatment groups, including placebo and different doses of Levetiracetam. The data is shown in a bar graph format with varying percentages for each group. The total number of patients in each group is also provided.*

FDA Label Image

Figure 2 (Levetiracetam 9)

This appears to be a description related to a study or experiment involving different dosages of Levetiracetam and a placebo. The text includes percentages indicating different dosages and sample sizes for each group treated with Levetiracetam at 1000mg/day and 2000mg/day, as well as the placebo group. The data seems to be organized for comparison or analysis purposes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.